Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Groove Botanicals (GRVE) EBITDA (2016 - 2025)

Groove Botanicals' EBITDA history spans 8 years, with the latest figure at -$59773.0 for Q1 2017.

  • On a quarterly basis, EBITDA rose 97.51% to -$59773.0 in Q1 2017 year-over-year; TTM through Mar 2017 was -$232645.0, a 91.59% increase, with the full-year FY2025 number at -$130834.0, up 50.92% from a year prior.
  • EBITDA hit -$59773.0 in Q1 2017 for Groove Botanicals, up from -$120261.0 in the prior quarter.
  • Over the last five years, EBITDA for GRVE hit a ceiling of -$24337.0 in Q3 2016 and a floor of -$2.4 million in Q1 2016.
  • Historically, EBITDA has averaged -$251337.8 across 5 years, with a median of -$114976.0 in 2015.
  • Biggest five-year swings in EBITDA: plummeted 2949.28% in 2016 and later skyrocketed 97.51% in 2017.
  • Tracing GRVE's EBITDA over 5 years: stood at -$123970.0 in 2013, then soared by 31.16% to -$85336.0 in 2014, then plummeted by 64.83% to -$140656.0 in 2015, then rose by 14.5% to -$120261.0 in 2016, then skyrocketed by 50.3% to -$59773.0 in 2017.
  • Business Quant data shows EBITDA for GRVE at -$59773.0 in Q1 2017, -$120261.0 in Q4 2016, and -$24337.0 in Q3 2016.